1. Home
  2. CRUS vs LSBPW Comparison

CRUS vs LSBPW Comparison

Compare CRUS & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRUS
  • LSBPW
  • Stock Information
  • Founded
  • CRUS 1984
  • LSBPW N/A
  • Country
  • CRUS United States
  • LSBPW China
  • Employees
  • CRUS N/A
  • LSBPW 758
  • Industry
  • CRUS Semiconductors
  • LSBPW Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRUS Technology
  • LSBPW Health Care
  • Exchange
  • CRUS Nasdaq
  • LSBPW Nasdaq
  • Market Cap
  • CRUS N/A
  • LSBPW N/A
  • IPO Year
  • CRUS 1989
  • LSBPW N/A
  • Fundamental
  • Price
  • CRUS $100.56
  • LSBPW $0.05
  • Analyst Decision
  • CRUS Buy
  • LSBPW
  • Analyst Count
  • CRUS 6
  • LSBPW 0
  • Target Price
  • CRUS $133.00
  • LSBPW N/A
  • AVG Volume (30 Days)
  • CRUS 676.0K
  • LSBPW N/A
  • Earning Date
  • CRUS 02-04-2025
  • LSBPW N/A
  • Dividend Yield
  • CRUS N/A
  • LSBPW N/A
  • EPS Growth
  • CRUS 136.77
  • LSBPW N/A
  • EPS
  • CRUS 5.89
  • LSBPW N/A
  • Revenue
  • CRUS $1,906,694,000.00
  • LSBPW N/A
  • Revenue This Year
  • CRUS $1.85
  • LSBPW N/A
  • Revenue Next Year
  • CRUS $4.34
  • LSBPW N/A
  • P/E Ratio
  • CRUS $17.07
  • LSBPW N/A
  • Revenue Growth
  • CRUS 8.24
  • LSBPW N/A
  • 52 Week Low
  • CRUS $75.92
  • LSBPW N/A
  • 52 Week High
  • CRUS $147.46
  • LSBPW N/A
  • Technical
  • Relative Strength Index (RSI)
  • CRUS 36.47
  • LSBPW N/A
  • Support Level
  • CRUS $99.20
  • LSBPW N/A
  • Resistance Level
  • CRUS $107.89
  • LSBPW N/A
  • Average True Range (ATR)
  • CRUS 2.94
  • LSBPW 0.00
  • MACD
  • CRUS -0.19
  • LSBPW 0.00
  • Stochastic Oscillator
  • CRUS 15.80
  • LSBPW 0.00

About LSBPW LakeShore Biopharma Co. Ltd

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: